Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
Conditions
- Chronic Lymphocytic Leukemia (CLL)
Interventions
- DRUG: Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide
Sponsor
Hackensack Meridian Health
Collaborators